Cell therapy of refractory Crohn's disease

Bulletin of Experimental Biology and Medicine

Volumn 156, Issue 1, 2013, Pages 139-145

  Knyazev, O V ^a   Parfenov, A I ^a   Shcherbakov, P L ^a   Ruchkina, I N ^a   Konoplyannikov, A G ^b  

^a Central Research Institute of Gastroenterology   (Russian Federation)

^b MEDICAL RADIOLOGICAL RESEARCH CENTER   (Russian Federation)

Author keywords

biotherapy; Crohn's disease; inflammatory bowel diseases; mesenchymal stromal cells

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGENIC MESENCHYMAL STROMAL BONE MARROW CELL; ARTICLE; BONE MARROW CELL; CELL THERAPY; CROHN DISEASE; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STROMA CELL; REMISSION; SAFETY;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; CELLS, CULTURED; COLON; CROHN DISEASE; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84891634618     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-013-2297-8     Document Type: Article

References (19)

1. E. A. Belousova, Russ. Med. Zh., No. 2, 88-95 (2005).
2. A. F. Tsyb, A. G. Konoplyannikov, A. I. Kolesnikova, et al., Vestn. Ross. Akad. Med. Nauk., 59, No. 9, 71-76 (2004).
3. R. Abdi, P. Fiorina, C. N. Adra, et al., Diabetes, 57, No. 7, 1767-1767 (2008).
4. F. C. Breedveld, Lancet, No. 355, 735-740 (2000).
5. A. Chapel, J. M. Bertho, M. Bensidhoum, et al., J. Gene. Med., 5, No. 12, 1028-1038 (2003).
6. P. E. Drakos, A. Nagler, and R. Or, Am. J. Hematol., 43, No. 3, 157-158 (1993).
7. G. W. Dryden, Expert Opin. Biol. Ther., 9, No. 7, 841-847 (2009).
8. W. A. Faubion, E. V. Loftus, W. S. Harmsen, et al., Gastroenterology, 121, No. 2, 255-260 (2001).
9. C. Fiocchi, Gastroenterology, 115, No. 1, 182-205 (1998).
10. M. Krampera, S. Glennie, J. Dyson, et al., Blood, 101, No. 9, 3722-3729 (2003).
11. H. Malchow, K. Ewe, J. W. Brandes, et al., Gastroenterology, 86, No. 2, 249-266 (1984).
12. R. Meisel, A. Zibert, M. Laryea, et al., Blood, 103, No. 12, 4619-4621 (2004).
13. T. J. Nelson, A. Behfar, and A. Terzic, Clin. Transl. Sci., 1, No. 2, 168-171 (2008).
14. Y. Oyama, A. E. Traynor, W. Barr, and R. K. Burt, Bone Marrow Transplantat., 32, Suppl. 1, S81-S83 (2003).
15. A. Rabinovitch and W. L. Suarez-Pinzon, Rev. Endocr. Metab. Disord., 4, No. 3, 291-299 (2003).
16. P. Rutgeerts, B. G. Feagan, G. R. Lichtenstein, et al., Gastroenterology, 126, No. 2, 402-413 (2004).
17. W. J. Sandborn, Z. G. Feagan, S. Z. Hanauer, et al., Gastroenterology, 122, No. 2, 512-530 (2002).
18. R. W. Summers, D. M. Switz, J. T. Sessions, et al., Gastroenterology, 77, No. 4, Pt. 2, 847-869 (1979).
19. A. Uccelli, V. Pistoia, and L. Moretta, Trends Immunol., 28, No. 5, 219-226 (2007).